Medical Research
Northeast Als Consortium Inc
BOSTON, MA
Total revenue
$2.1M
Total expenses
$555K
Net assets
$2.8M
Grants received
$1.6M
16 grants
EIN
562547779
Tax year
2024
Mission
Our mission is to translate scientific advances into new treatments for people with amyotrophic lateral sclerosis (als) and motor neuron disease (mnd) as rapidly as possible. To achieve our goal, neals functions as an academic research consortium and a resource tool for the als community. Neals is committed to the principles of open scientific communication, peer review, full and open disclosure of potential conflicts of interest, and democratic governance of its organization and activities.
Financials
FY 2024
Revenue
Expenses
People
12 listed
ROBERT H BROWNMD DPHIL
SAB, CHAIR
—
1 hrs/wk
GALE KITTLE
CLINICAL EVALUATOR MEMBER
—
1 hrs/wk
JEFFREY ROTHSTEINMDPHD
SAB, CHAIR
—
1 hrs/wk
TIMOTHY MILLER MD PHD
SAB, CHAIR
—
1 hrs/wk
JINSY ANDREWS MD MSC
CO-CHAIR
—
5 hrs/wk
CHRISTINA FOURNIER
INVESTIGATOR MEMBER
—
1 hrs/wk
NICOLE TURCOTTE
COORDINATOR MEMBER
—
1 hrs/wk
MATTHEW HARMS
INVESTIGATOR MEMBER
—
1 hrs/wk
SABRINA PAGANONI
INVESTIGATOR MEMBER
—
1 hrs/wk
ZACHARY SIMMONS
INVESTIGATOR MEMBER
—
1 hrs/wk
JAMES BERRY
CO-CHAIR
—
5 hrs/wk
CARLY ALLEN
DIRECTOR OF OPERATION
—
40 hrs/wk
Grants received
Showing 16 of 16
Funded by
$1.6M from 6 funders · 16 grants · 2018–2024
$991K · 6 grants · 2018–2022
$406K · 4 grants · 2020–2022
$121K · 3 grants · 2018–2021
$100K · 1 grant · 2024
$5K · 1 grant · 2023
$5K · 1 grant · 2019